{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T07:22:48Z","timestamp":1771572168675,"version":"3.50.1"},"reference-count":347,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007059","name":"Palacky University Olomouc","doi-asserted-by":"publisher","award":["IGA_PrF_2024_028"],"award-info":[{"award-number":["IGA_PrF_2024_028"]}],"id":[{"id":"10.13039\/501100007059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007059","name":"Palacky University Olomouc","doi-asserted-by":"publisher","award":["IGA_PrF_2025_014"],"award-info":[{"award-number":["IGA_PrF_2025_014"]}],"id":[{"id":"10.13039\/501100007059","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ejmech.2025.117526","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T21:20:59Z","timestamp":1742505659000},"page":"117526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The Liebeskind\u2013Srogl cross-coupling reaction towards the synthesis of biologically active compounds"],"prefix":"10.1016","volume":"290","author":[{"given":"Jan","family":"Chas\u00e1k","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacy","family":"Janicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8380-073X","authenticated-orcid":false,"given":"Lucie","family":"Brul\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117526_bib1","doi-asserted-by":"crossref","first-page":"11260","DOI":"10.1021\/ja005613q","article-title":"Thiol Ester\u2212Boronic acid coupling. A mechanistically unprecedented and general ketone synthesis","volume":"122","author":"Liebeskind","year":"2000","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117526_bib2","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1002\/anie.200802842","article-title":"The Liebeskind-Srogl C-C cross-coupling reaction","volume":"48","author":"Prokopcov\u00e1","year":"2009","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2025.117526_bib3","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ajoc.201700651","article-title":"The liebeskind\u2013srogl cross-coupling reaction and its synthetic applications","volume":"7","author":"Cheng","year":"2018","journal-title":"Asian J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/0975-7406.171694","article-title":"Current status of pyrazole and its biological activities","volume":"8","author":"Naim","year":"2016","journal-title":"J. Pharm. BioAllied Sci."},{"key":"10.1016\/j.ejmech.2025.117526_bib5","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1002\/anie.200906781","article-title":"Three-component reaction using the bestmann\u2013ohira reagent: a regioselective synthesis of phosphonyl pyrazole rings","volume":"49","author":"Mohanan","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.117526_bib6","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1021\/ol101365x","article-title":"Reagent-controlled oxidative aromatization in iodocyclization: switchable access to dihydropyrazoles and pyrazoles","volume":"12","author":"Okitsu","year":"2010","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib7","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1016\/j.tetlet.2011.08.168","article-title":"Regioselective synthesis of multisubstituted pyrazoles via cyclocondensation of \u03b2-thioalkyl-\u03b1,\u03b2-unsaturated ketones with hydrazines","volume":"52","author":"Jin","year":"2011","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115172","article-title":"Application and synthesis of thiazole ring in clinically approved drugs","volume":"250","author":"Niu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib9","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.2174\/1568026616666160506130731","article-title":"Thiazole: a review on chemistry, synthesis and therapeutic importance of its derivatives","volume":"16","author":"Chhabria","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202300414","article-title":"Mini review on the synthesis and biological impact of thiazoles","volume":"8","author":"Ayman","year":"2023","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2025.117526_bib11","series-title":"Compr. Org. Name React. Reagents","first-page":"1330","article-title":"Hantzsch thiazole synthesis","author":"Wang","year":"2010"},{"key":"10.1016\/j.ejmech.2025.117526_bib12","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1021\/jm300388h","article-title":"Discovery and optimization of a series of 2-aryl-4-amino-5-(3\u2019,4\u2019,5\u2019-trimethoxybenzoyl)thiazoles as novel anticancer agents","volume":"55","author":"Romagnoli","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.tetlet.2020.152152","article-title":"Liebeskind-Srogl-type cross-coupling reaction of azole-2-thiones with triarylbismuthines: synthesis of 2-arylazoles","volume":"61","author":"Murata","year":"2020","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib14","doi-asserted-by":"crossref","first-page":"86832","DOI":"10.1039\/C5RA17827D","article-title":"An efficient desulfitative C\u2013C cross coupling of fused thiazolidine-2-thione with boronic acids and boronic acid pinacol esters: formation of fused thiazoles","volume":"5","author":"Rajaguru","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117526_bib15","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1021\/jacs.8b13534","article-title":"Ni-catalyzed reductive liebeskind\u2013srogl alkylation of heterocycles","volume":"141","author":"Ma","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117526_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1517\/13543776.2014.999764","article-title":"Therapeutic potential of benzothiazoles: a patent review (2010 - 2014)","volume":"25","author":"Kamal","year":"2015","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2025.117526_bib17","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1039\/C7CC08181B","article-title":"Nickel-catalyzed amination of aryl fluorides with primary amines","volume":"54","author":"Harada","year":"2018","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2025.117526_bib18","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1002\/cctc.201900707","article-title":"Copper-assisted synthesis of novel pyrazolo[3,4-d]thiazoles","volume":"11","author":"Ostache","year":"2019","journal-title":"ChemCatChem"},{"key":"10.1016\/j.ejmech.2025.117526_bib19","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cclet.2015.05.012","article-title":"New synthetic approach for the preparation of 2-aryl-thiazolo[4,5-b]pyridines via Liebeskind\u2013Srogl reaction","volume":"26","author":"Peng","year":"2015","journal-title":"Chinese Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13065-019-0531-9","article-title":"A comprehensive review on biological activities of oxazole derivatives","volume":"13","author":"Kakkar","year":"2019","journal-title":"BMC Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/chin.201517298","article-title":"Oxazolines: their synthesis and biological activity","volume":"46","author":"Bansal","year":"2015","journal-title":"ChemInform"},{"key":"10.1016\/j.ejmech.2025.117526_bib22","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1021\/acs.chemrev.0c00844","article-title":"Further developments and applications of oxazoline-containing ligands in asymmetric catalysis","volume":"121","author":"Connon","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.117526_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2024.134363","article-title":"Recent developments in the metal-free synthesis of oxazoles","volume":"169","author":"Wanjari","year":"2025","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2025.117526_bib24","article-title":"A review of the synthesis of oxazoline derivatives","author":"Pereira","year":"2024","journal-title":"Curr. Org. Synth."},{"key":"10.1016\/j.ejmech.2025.117526_bib25","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1021\/cr60273a003","article-title":"Oxazolines. Their preparation, reactions, and applications","volume":"71","author":"Frump","year":"1971","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.117526_bib26","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1080\/00397911.2021.1986843","article-title":"Synthetic approaches for oxazole derivatives: a review","volume":"51","author":"Neha","year":"2021","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2025.117526_bib27","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1055\/s-2007-965932","article-title":"Benzylsulfanyloxazolines in palladium-catalyzed cross-coupling reactions: a novel approach to chiral oxazolines","volume":"2007","author":"Leconte Laurent","year":"2007","journal-title":"Synthesis (Stuttg)"},{"key":"10.1016\/j.ejmech.2025.117526_bib28","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1021\/ol027453o","article-title":"Copper(I)-Promoted palladium-catalyzed cross-coupling of unsaturated tri-n-butylstannane with heteroaromatic thioether","volume":"5","author":"Alphonse","year":"2003","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib29","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/med.20007","article-title":"Imidazoline binding sites and their ligands: an overview of the different chemical structures","volume":"24","author":"Dardonville","year":"2004","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.117526_bib30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ejmech.2014.11.028","article-title":"Biologically active compounds based on the privileged 2-imidazoline scaffold: the world beyond adrenergic\/imidazoline receptor modulators","volume":"97","author":"Krasavin","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib31","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1007\/s11696-024-03496-1","article-title":"Biological impacts of imidazoline derivatives","volume":"78","author":"Kabi","year":"2024","journal-title":"Chem. Pap."},{"key":"10.1016\/j.ejmech.2025.117526_bib32","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/13543776.2016.1210128","article-title":"Imidazoline scaffold in medicinal chemistry: a patent review (2012\u20132015), Expert Opin","volume":"26","author":"S\u0105czewski","year":"2016","journal-title":"Ther. Pat."},{"key":"10.1016\/j.ejmech.2025.117526_bib33","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1092472","article-title":"In vivo activation of the p53 pathway by small-molecule antagonists of MDM2","volume":"303","author":"Vassilev","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.117526_bib34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35042675","article-title":"Surfing the p53 network","volume":"408","author":"Vogelstein","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117526_bib35","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1002\/adsc.202000709","article-title":"Recent advances in the synthesis of imidazolines (2009\u20132020)","volume":"362","author":"Al Mehedi","year":"2020","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.ejmech.2025.117526_bib36","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.1021\/jo070840x","article-title":"A resource-efficient and highly flexible procedure for a three-component synthesis of 2-imidazolines","volume":"72","author":"Elders","year":"2007","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1039\/B713065A","article-title":"Efficient C2 functionalisation of 2H-2-imidazolines","volume":"6","author":"Bon","year":"2008","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib38","first-page":"3759","article-title":"Novel multicomponent reaction for the combinatorial synthesis of 2-imidazolines, org","volume":"5","author":"Bon","year":"2003","journal-title":"Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib39","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1039\/B713065A","article-title":"Efficient C2 functionalisation of 2H-2-imidazolines","volume":"6","author":"Bon","year":"2008","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.9734\/jpri\/2021\/v33i45A32746","article-title":"Recent developments and biological activities of 5-oxo-imidazolones derivatives: a review","volume":"33","author":"Yellasubbaiah","year":"2021","journal-title":"J. Pharm. Res. Int."},{"key":"10.1016\/j.ejmech.2025.117526_bib41","first-page":"2613","article-title":"New zwitterionic imidazolones with enhanced water solubility and bioavailability: synthesis, anticancer activity, and molecular docking","volume":"5","author":"Abu-Jabal","year":"2023","journal-title":"Chemistry (Easton)."},{"key":"10.1016\/j.ejmech.2025.117526_bib42","doi-asserted-by":"crossref","first-page":"20120","DOI":"10.1039\/D4RA03157A","article-title":"Synthesis and biological research of new imidazolone-sulphonamide-pyrimidine hybrids as potential EGFR-TK inhibitors and apoptosis-inducing agents","volume":"14","author":"Binjawhar","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117526_bib43","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1021\/acsmedchemlett.7b00230","article-title":"1-Benzyl-3-aryl-2-thiohydantoin derivatives as new anti-trypanosoma brucei agents: SAR and in vivo efficacy","volume":"8","author":"Buchynskyy","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib44","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1016\/j.bmcl.2006.06.087","article-title":"Binding mode of new (thio)hydantoin inhibitors of fatty acid amide hydrolase: comparison with two original compounds, OL-92 and JP104","volume":"16","author":"Michaux","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib45","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1002\/jhet.4120","article-title":"One-pot synthesis of new hydantoin (thiohydantoin) derivatives and evaluation of their antibacterial and antioxidant activities","volume":"57","author":"Ghasempour","year":"2020","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib46","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1016\/j.bmc.2016.06.056","article-title":"Synthesis and biological evaluation of 3-substituted 5-benzylidene-1-methyl-2-thiohydantoins as potent NADPH oxidase (NOX) inhibitors","volume":"24","author":"Bae","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib47","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1055\/s-0030-1260259","article-title":"Thiohydantoins: selective N- and S-functionalization for liebeskind-srogl reaction study","volume":"2011","author":"Gosling Patrick","year":"2011","journal-title":"Synthesis (Stuttg)."},{"key":"10.1016\/j.ejmech.2025.117526_bib48","series-title":"A Review on the Medicinal Importance of Pyridine Derivatives","author":"Altaf","year":"2015"},{"key":"10.1016\/j.ejmech.2025.117526_bib49","doi-asserted-by":"crossref","unstructured":"A. Hantzsch, Condensationsprodukte aus Aldehydammoniak und ketonartigen Verbindungen, Berichte Der Dtsch. Chem. Gesellschaft 14 (1881) 1637\u20131638.","DOI":"10.1002\/cber.18810140214"},{"key":"10.1016\/j.ejmech.2025.117526_bib50","series-title":"IntechOpen, Rijeka","article-title":"Pyridine: a useful ligand in transition metal complexes","author":"Pal","year":"2018"},{"key":"10.1016\/j.ejmech.2025.117526_bib51","series-title":"Naturally Isolated Pyridine Compounds Having Pharmaceutical Applications","author":"Naushad","year":"2022"},{"key":"10.1016\/j.ejmech.2025.117526_bib52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1039\/D4MD00632A","article-title":"A decade of pyridine-containing heterocycles in US FDA approved drugs: a medicinal chemistry-based analysis","volume":"16","author":"Dwivedi","year":"2025","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib53","series-title":"Cancer Sensitizing Agents Chemother","first-page":"31","article-title":"Chapter 2 - ALK rearranged lung cancer: TKI treatment and outcome","author":"Collazo-Lorduy","year":"2021"},{"key":"10.1016\/j.ejmech.2025.117526_bib54","doi-asserted-by":"crossref","first-page":"15385","DOI":"10.1039\/D2RA01571D","article-title":"Pyridine: the scaffolds with significant clinical diversity","volume":"12","author":"De","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117526_bib55","article-title":"Advances in synthesis, medicinal properties and biomedical applications of pyridine derivatives: a comprehensive review","volume":"12","author":"Sahu","year":"2024","journal-title":"Eur. J. Med. Chem. Reports"},{"key":"10.1016\/j.ejmech.2025.117526_bib56","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/ejoc.201001583","article-title":"Regioselective syntheses of 2,3-substituted pyridines by orthogonal cross-coupling strategies","volume":"2011","author":"Koley","year":"2011","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib57","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jhet.2005","article-title":"Pd(0)-Catalyzed Cu(I)-Thiophene-2-carboxylate-mediated cross-coupling of heteroaromatic thioethers and boronic acids\u2014first liebeskind\u2013srogl reaction in water","volume":"50","author":"Koley","year":"2013","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib58","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1080\/10406638.2022.2092873","article-title":"Advances in the synthesis and bio-applications of pyrazine derivatives: a review","volume":"43","author":"Choudhary","year":"2023","journal-title":"Polycycl. Aromat. Compd."},{"key":"10.1016\/j.ejmech.2025.117526_bib59","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1134\/S1068162022050259","article-title":"Pyrazine derivatives\u2014versatile scaffold","volume":"48","author":"Tambat","year":"2022","journal-title":"Russ. J. Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib60","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1517\/13543776.2014.982533","article-title":"Pyrazine derivatives: a patent review (June 2012 \u2013 present), Expert Opin","volume":"25","author":"Dolezal","year":"2015","journal-title":"Ther. Pat."},{"key":"10.1016\/j.ejmech.2025.117526_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27031112","article-title":"Pyrazine and phenazine heterocycles: platforms for total synthesis and drug discovery","volume":"27","author":"Huigens","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117526_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202000064","article-title":"Pyrazines: synthesis and industrial application of these valuable flavor and fragrance compounds","volume":"15","author":"Mortzfeld","year":"2020","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.ejmech.2025.117526_bib63","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/jo061935m","article-title":"Synthesis of symmetrical and unsymmetrical pyrazines","volume":"72","author":"Taber","year":"2007","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib64","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1021\/jo702656v","article-title":"A novel and versatile entry to asymmetrically substituted pyrazines","volume":"73","author":"Mehta","year":"2008","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib65","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1055\/s-0031-1289714","article-title":"Efficient preparation of tetrasubstituted pyrazines starting from pyrazin-2(1H)-ones","volume":"44","author":"Modha","year":"2012","journal-title":"Synthesis (Stuttg)"},{"key":"10.1016\/j.ejmech.2025.117526_bib66","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.bmcl.2016.03.067","article-title":"Synthesis and evaluation of carbamate and aryl ether substituted pyrazinones as corticotropin releasing factor-1 (CRF1) receptor antagonists","volume":"26","author":"Ahuja","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib67","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/S0960-894X(03)00410-4","article-title":"Structure-based drug design of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex","volume":"13","author":"South","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib68","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0026-895X(25)13208-2","article-title":"Substituted pyrazinones, a new class of allosteric modulators for gamma-aminobutyric acidA receptors","volume":"44","author":"Im","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117526_bib69","series-title":"HIV Inhibiting Pyrazinone Derivatives","author":"Janssen","year":"2002"},{"key":"10.1016\/j.ejmech.2025.117526_bib70","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1021\/jm040829e","article-title":"Design, synthesis, and SAR of a novel pyrazinone series with non-nucleoside HIV-1 reverse transcriptase inhibitory activity","volume":"48","author":"Heeres","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib71","series-title":"Method of Modulating Stress-Activated Protein Kinase System","author":"Blatt","year":"2018"},{"key":"10.1016\/j.ejmech.2025.117526_bib72","doi-asserted-by":"crossref","first-page":"9713","DOI":"10.1016\/j.tet.2012.09.039","article-title":"Design and synthesis of 2(1H)-pyrazinones as inhibitors of protein kinases","volume":"68","author":"Caldwell","year":"2012","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2025.117526_bib73","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.bmcl.2004.11.011","article-title":"Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors","volume":"15","author":"Lindsley","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.117067","article-title":"Design, synthesis and biological evaluation of novel pyrazinone derivatives as PI3K\/HDAC dual inhibitors","volume":"74","author":"Wang","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib75","series-title":"Biaryl Substituted Pyrazinones as Sodium Channel Blockers","author":"Liang","year":"2005"},{"key":"10.1016\/j.ejmech.2025.117526_bib76","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1016\/S0040-4020(03)00732-4","article-title":"Synthesis and conformational analysis of Substance P antagonist analogues based on a 1,7-naphthyridine scaffold","volume":"59","author":"Rombouts","year":"2003","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2025.117526_bib77","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ejmech.2005.03.007","article-title":"Novel pyrazinone and pyridinone thrombin inhibitors incorporating weakly basic heterobicyclic P(1)-arginine mimetics","volume":"40","author":"Kranjc","year":"2005","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib78","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/ejoc.200200652","article-title":"Development of a functionalizable external \u03b2-turn mimic based on a cis-fused 1,7-naphthyridine scaffold","volume":"2003","author":"Rombouts","year":"2003","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib79","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.chembiol.2010.08.006","article-title":"A family of pyrazinone natural products from a conserved nonribosomal peptide synthetase in Staphylococcus aureus","volume":"17","author":"Zimmermann","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117526_bib80","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/ja.2016.79","article-title":"Pyrazinone protease inhibitor metabolites from Photorhabdus luminescens","volume":"69","author":"Park","year":"2016","journal-title":"J. Antibiot. (Tokyo)."},{"key":"10.1016\/j.ejmech.2025.117526_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21091116","article-title":"Bioactive 2(1H)-Pyrazinones and diketopiperazine alkaloids from a tunicate-derived actinomycete Streptomyces sp","volume":"21","author":"Shaala","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117526_bib82","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1039\/b704389a","article-title":"Palladium-catalyzed copper(i)-mediated cross-coupling of arylboronic acids and 2(1H)-pyrazinones facilitated by microwave irradiation with simultaneous cooling","volume":"5","author":"Singh","year":"2007","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib83","series-title":"The Chemistry of 2-(1h)-Pyrazinones inSolution and on Solid Support BT - Microwave-Assisted Synthesis of Heterocycles","first-page":"267","author":"Kaval","year":"2006"},{"key":"10.1016\/j.ejmech.2025.117526_bib84","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1021\/cc049882e","article-title":"Solid-phase synthesis of the 2(1H)-Pyrazinone scaffold: a new approach toward diversely substituted heterocycles","volume":"7","author":"Kaval","year":"2005","journal-title":"J. Comb. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib85","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1021\/cc060105j","article-title":"Transition metal-catalyzed orthogonal solid-phase decoration of the 2(1H)-Pyrazinone scaffold using a sulfur linker","volume":"9","author":"Kaval","year":"2007","journal-title":"J. Comb. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cbdv.200490173","article-title":"Pyrimidine as constituent of natural biologically active compounds","volume":"2","author":"Lagoja","year":"2005","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2025.117526_bib87","article-title":"Significance and biological importance of pyrimidine in the microbial world","volume":"2014","author":"Sharma","year":"2014","journal-title":"Int. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib88","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/jhet.4837","article-title":"A review on pyrimidine-based derivatives: synthesis and their biological application","volume":"61","author":"Islam","year":"2024","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.129833","article-title":"Synthesis and biological activity of pyrimidines-containing hybrids: focusing on pharmacological application","volume":"1230","author":"Zarenezhad","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117526_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24183234","article-title":"Synthesis and biological evaluation of disubstituted pyrimidines as selective 5-HT(2C) agonists","volume":"24","author":"Kim","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117526_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052329","article-title":"Synthesis of novel pyrido[1,2-c]pyrimidine derivatives with 6-Fluoro-3-(4-piperidynyl)-1,2-benzisoxazole moiety as potential SSRI and 5-HT(1A) receptor ligands","volume":"22","author":"Kr\u00f3l","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117526_bib92","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/chin.200243181","article-title":"Thermal\/microwave assisted synthesis of substituted tetrahydropyrimidines as potent calcium channel blockers","volume":"33","author":"Kumar","year":"2002","journal-title":"ChemInform"},{"key":"10.1016\/j.ejmech.2025.117526_bib93","doi-asserted-by":"crossref","first-page":"14214","DOI":"10.1021\/ja063645t","article-title":"Modified pyrimidines specifically bind the purine riboswitch","volume":"128","author":"Gilbert","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117526_bib94","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.1093\/nar\/gkp862","article-title":"5-Fluoro pyrimidines: labels to probe DNA and RNA secondary structures by 1D 19F NMR spectroscopy","volume":"37","author":"Puffer","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.117526_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2024.216285","article-title":"A critical review of coordination chemistry of pyrimidine and pyridazine compounds: bonding, chelation and corrosion inhibition","volume":"523","author":"Quadri","year":"2025","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.117526_bib96","doi-asserted-by":"crossref","unstructured":"A. Pinner, Ueber die Einwirkung von Acetessig\u00e4ther auf die Amidine, Berichte Der Dtsch. Chem. Gesellschaft 17 (1884) 2519\u20132520.","DOI":"10.1002\/cber.188401702173"},{"key":"10.1016\/j.ejmech.2025.117526_bib97","doi-asserted-by":"crossref","first-page":"12804","DOI":"10.1021\/jacs.5b09510","article-title":"A sustainable multicomponent pyrimidine synthesis","volume":"137","author":"Deibl","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117526_bib98","first-page":"148","article-title":"A review on recent progress in multicomponent reactions of pyrimidine synthesis, Drug Invent","volume":"5","author":"Gore","year":"2013","journal-title":"Today Off."},{"key":"10.1016\/j.ejmech.2025.117526_bib99","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1055\/s-0031-1290826","article-title":"A general regioselective synthesis of 2,4-diarylpyrimidines from 2- thiouracil through two orthogonal cross-coupling reactions","volume":"23","author":"\u010cer\u0148ov\u00e1 Radek","year":"2012","journal-title":"Synlett"},{"key":"10.1016\/j.ejmech.2025.117526_bib100","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.bmc.2010.12.006","article-title":"Preparation and evaluation of trisubstituted pyrimidines as phosphatidylinositol 3-kinase inhibitors. 3-Hydroxyphenol analogues and bioisosteric replacements","volume":"19","author":"Large","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib101","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1016\/j.bmcl.2011.03.084","article-title":"Synthesis and SAR of pyrimidine-based, non-nucleotide P2Y14 receptor antagonists","volume":"21","author":"Guay","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib102","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1016\/j.bmc.2008.01.013","article-title":"A new generation of adenosine receptor antagonists: from di- to trisubstituted aminopyrimidines","volume":"16","author":"van Veldhoven","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib103","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1021\/jm100843z","article-title":"Pyrimidine derivatives as potent and selective A3 adenosine receptor antagonists","volume":"54","author":"Yaziji","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib104","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1074\/jbc.M109.024844","article-title":"The novel calcineurin inhibitor CN585 has potent immunosuppressive properties in stimulated human T cells","volume":"285","author":"Erdmann","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib105","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1002\/ejoc.201403133","article-title":"Synthesis of soai type 2-Arylpyrimidine-5-carbaldehydes through desulfurative cross-coupling with arylboronic acids","volume":"2014","author":"V Maltsev","year":"2014","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib106","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1021\/ol500189s","article-title":"Synthesis of soai aldehydes for asymmetric autocatalysis by desulfurative cross-coupling","volume":"16","author":"V Maltsev","year":"2014","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib107","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1021\/acs.orglett.8b00502","article-title":"Boric ester and thiourea as coupling partners in a copper-mediated oxidative dehydrosulfurative carbon\u2013oxygen cross-coupling reaction","volume":"20","author":"Kim","year":"2018","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib108","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.1016\/j.tet.2017.10.010","article-title":"Dehydrosulfurative arylation with concomitant oxidative dehydrogenation for rapid access to pyrimidine derivatives","volume":"73","author":"Kim","year":"2017","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2025.117526_bib109","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1021\/acs.orglett.6b02617","article-title":"Dehydrosulfurative C\u2013N cross-coupling and concomitant oxidative dehydrogenation for one-step synthesis of 2-Aryl(alkyl)aminopyrimidines from 3,4-dihydropyrimidin-1H-2-thiones","volume":"18","author":"Phan","year":"2016","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib110","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/adsc.201300776","article-title":"Chemoselective carbon-carbon cross-coupling via palladium-catalyzed copper-mediated C\u2013S cleavage of disulfides","volume":"356","author":"Quan","year":"2014","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.ejmech.2025.117526_bib111","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/cbdd.14026","article-title":"Chemistry and biological evaluation of pyrido[4,3-d]pyrimidines: a review","volume":"99","author":"Yadav","year":"2022","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2025.117526_bib112","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s11030-023-10623-9","article-title":"Developments of pyridodipyrimidine heterocycles and their biological activities","volume":"28","author":"Hammouda","year":"2024","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2025.117526_bib113","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/cbdd.13800","article-title":"An overview on synthetic and pharmaceutical prospective of pyrido[2,3-d]pyrimidines scaffold","volume":"97","author":"Yadav","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2025.117526_bib114","doi-asserted-by":"crossref","first-page":"6872","DOI":"10.1039\/D3RA00056G","article-title":"Medicinal chemistry perspective of pyrido[2,3-d]pyrimidines as anticancer agents","volume":"13","author":"Kumar","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117526_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134435","article-title":"One-pot three component synthesis of pyrido[2,3-d]pyrimidines and benzo[4,5]imidazo[1,2-a]-pyrimidine-3-carbonitrile catalyzed by acidic ionic liquid immobilized on nanoporous TiO2","volume":"1274","author":"Nezhadramezan-Ghasemabadi","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117526_bib116","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1021\/jo300189q","article-title":"Access and regioselective transformations of 6-substituted 4-Aryl-2,8-dichloropyrido[3,2-d]pyrimidine compounds","volume":"77","author":"Bouscary-Desforges","year":"2012","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib117","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1021\/jo201834d","article-title":"Regioselective synthesis of 2,8-disubstituted 4-Aminopyrido[3,2-d]pyrimidine-6-carboxylic acid methyl ester compounds","volume":"77","author":"Bouscary-Desforges","year":"2012","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib118","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/17415993.2019.1590581","article-title":"UV Light-mediated regioselective methylsulfanyl discrimination via Pd-catalyzed cross-coupling reactions of 2,4-dimethylsulfanylpyrido[2,3-d]pyrimidines","volume":"40","author":"Riadi","year":"2019","journal-title":"J. Sulfur Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib119","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s11696-017-0325-2","article-title":"Photochemical route for the synthesis of novel 2-monosubstituted pyrido[2,3-d]pyrimidines by palladium-catalyzed cross-coupling reactions","volume":"72","author":"Riadi","year":"2018","journal-title":"Chem. Pap."},{"key":"10.1016\/j.ejmech.2025.117526_bib120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ejmech.2018.08.023","article-title":"Pyrrolopyrimidines: an update on recent advancements in their medicinal attributes","volume":"157","author":"Pathania","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib121","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1021\/acs.chemrev.5b00483","article-title":"Synthetic entries to and biological activity of pyrrolopyrimidines","volume":"116","author":"De Coen","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.117526_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21608\/aprh.2017.16155","article-title":"Synthesis strategies and biological value of pyrrole and pyrrolopyrimidine","volume":"1","author":"Mohamed","year":"2017","journal-title":"J. Adv. Pharm. Res."},{"key":"10.1016\/j.ejmech.2025.117526_bib123","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/med.21465","article-title":"Pyrrolo[2,3-d]pyrimidine (7-deazapurine) as a privileged scaffold in design of antitumor and antiviral nucleosides","volume":"37","author":"Perl\u00edkov\u00e1","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.117526_bib124","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1002\/ejoc.201800163","article-title":"Deazapurine analogues bearing a 1H-Pyrazolo[3,4-b]pyridin-3(2H)-one core: synthesis and biological activity","volume":"2018","author":"Supe","year":"2018","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib125","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.889737","article-title":"Phosphonates and phosphonate prodrugs in medicinal chemistry: past successes and future prospects","volume":"10","author":"Kre\u010dmerov\u00e1","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib126","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.1002\/ejoc.201402882","article-title":"Chemoselective synthesis of 4,5-Diarylpyrrolo[2,3-d]pyrimidines (6,7-diaryl-7-deazapurines) by consecutive Suzuki and liebeskind\u2013srogl cross-couplings","volume":"2014","author":"Kr\u00f6mer","year":"2014","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib127","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.1002\/ejoc.201500625","article-title":"A strategy for the triarylation of pyrrolo-pyrimidines by using microwave-promoted cross-coupling reactions","volume":"2015","author":"Prieur","year":"2015","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib128","first-page":"245","article-title":"The combinatorial synthesis of purine, pyrimidine and triazine-based libraries, QSAR comb","volume":"23","author":"Bork","year":"2004","journal-title":"Sci."},{"key":"10.1016\/j.ejmech.2025.117526_bib129","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200154","article-title":"Pyrazolopyrimidines as attractive pharmacophores in efficient drug design: a recent update","volume":"355","author":"Dorababu","year":"2022","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2025.117526_bib130","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.2174\/1381612829666221102162000","article-title":"Medicinal chemistry of pyrazolopyrimidine scaffolds substituted with different heterocyclic nuclei","volume":"28","author":"Elgemeie","year":"2022","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2025.117526_bib131","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1039\/C7RA12246B","article-title":"Three successive and regiocontroled palladium cross-coupling reactions to easily synthesize novel series of 2,4,6-tris(het)aryl pyrido[1\u2032,2\u2032:1,5]pyrazolo[3,4-d]pyrimidines","volume":"8","author":"Belaroussi","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117526_bib132","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1016\/j.bmc.2005.05.043","article-title":"Synthesis of novel substituted 2-phenylpyrazolopyridines with potent activity against herpesviruses","volume":"13","author":"Gudmundsson","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib133","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1021\/jm980671w","article-title":"Discovery of 6-Oxo-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1(6H)-pyridazinebutanoic acid (FK 838): a novel non-xanthine adenosine A1 receptor antagonist with potent diuretic activity","volume":"42","author":"Akahane","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib134","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1016\/j.bmcl.2008.09.040","article-title":"The identification of pyrazolo[1,5-a]pyridines as potent p38 kinase inhibitors","volume":"18","author":"Cheung","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib135","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1021\/ol0519745","article-title":"Pyrazolo[1,5-a]pyridines as p38 kinase inhibitors","volume":"7","author":"Stevens","year":"2005","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib136","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1021\/jm200385u","article-title":"Synthesis of a novel series of tricyclic dihydrofuran derivatives: discovery of 8,9-Dihydrofuro[3,2-c]pyrazolo[1,5-a]pyridines as melatonin receptor (MT1\/MT2) ligands","volume":"54","author":"Koike","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib137","first-page":"114","article-title":"Recent progress in biological activities of dihydropyrimidine derivatives: an updated mini-review","volume":"6","author":"Elshamsy","year":"2023","journal-title":"J. Adv. Biomed. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2025.117526_bib138","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2174\/1389557521666210920120457","article-title":"An overview of synthesis and biological activity of dihydropyrimidine derivatives","volume":"22","author":"Dudhe","year":"2022","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib139","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1021\/jm00130a029","article-title":"Dihydropyrimidines: novel calcium antagonists with potent and long-lasting vasodilative and anti-hypertensive activity","volume":"32","author":"Cho","year":"1989","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib140","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1021\/jm990612y","article-title":"In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective \u03b11A receptor antagonists for the treatment of benign prostatic hyperplasia","volume":"43","author":"Barrow","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib141","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1021\/jm990200p","article-title":"Design and synthesis of novel \u03b11a adrenoceptor-selective antagonists. 1. Structure\u2212Activity relationship in dihydropyrimidinones","volume":"42","author":"Nagarathnam","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib142","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1074-5521(00)00101-0","article-title":"Dissecting cellular processes using small molecules: identification of colchicine-like, taxol-like and other small molecules that perturb mitosis","volume":"7","author":"Haggarty","year":"2000","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117526_bib143","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.286.5441.971","article-title":"Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen","volume":"286","author":"Mayer","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.117526_bib144","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1021\/jo00110a021","article-title":"Novel alkaloids from the sponge batzella sp.: inhibitors of HIV gp120-human CD4 binding","volume":"60","author":"Patil","year":"1995","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib145","doi-asserted-by":"crossref","DOI":"10.1128\/mSphereDirect.00131-18","article-title":"The heteroaryldihydropyrimidine Bay 38-7690 induces hepatitis B virus core protein aggregates associated with promyelocytic leukemia nuclear bodies in infected cells","volume":"3","author":"Huber","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.ejmech.2025.117526_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104557","article-title":"BAY 41-4109-mediated aggregation of assembled and misassembled HBV capsids in cells revealed by electron microscopy","volume":"169","author":"Rat","year":"2019","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ejmech.2025.117526_bib147","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.1077215","article-title":"Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids","volume":"299","author":"Deres","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2025.117526_bib148","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010204","article-title":"Bay41-4109-induced aberrant polymers of hepatitis b capsid proteins are removed via STUB1-promoted p62-mediated macroautophagy","volume":"18","author":"Lin","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2025.117526_bib149","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1021\/ol036496h","article-title":"Tunable carbon-carbon and carbon-sulfur cross-coupling of boronic acids with 3,4-dihydropyrimidine-2-thiones","volume":"6","author":"Lengar","year":"2004","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib150","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3762\/bjoc.7.150","article-title":"Synthesis of diverse dihydropyrimidine-related scaffolds by fluorous benzaldehyde-based Biginelli reaction and post-condensation modifications","volume":"7","author":"Piqani","year":"2011","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib151","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.tetlet.2012.03.067","article-title":"Optimized Liebeskind\u2013Srogl coupling reaction between dihydropyrimidines and tributyltin compounds","volume":"53","author":"Sun","year":"2012","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib152","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.1021\/jo900848s","article-title":"Palladium(0)-Catalyzed, copper(I)-Mediated coupling of cyclic thioamides with alkenylboronic acids, organostannanes, and siloxanes","volume":"74","author":"Arshad","year":"2009","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib153","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1002\/adsc.201200402","article-title":"A domino desulfitative coupling\/acylation\/hydration process cocatalyzed by copper(I) and palladium(II): synthesis of highly substituted and functionalized pyrimidines","volume":"354","author":"Quan","year":"2012","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.ejmech.2025.117526_bib154","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1002\/cmdc.202100083","article-title":"Recent developments on the synthesis and biological activities of fused pyrimidinone derivatives","volume":"16","author":"Seboletswe","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117526_bib155","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1074\/jbc.M413140200","article-title":"Monastrol inhibition of the mitotic kinesin Eg5","volume":"280","author":"Cochran","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib156","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/jhet.4855","article-title":"Medicinal perspective of a promising scaffold \u2013 dihydropyrimidinones: a review","volume":"61","author":"Sarvaiya","year":"2024","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib157","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2174\/1573407212666160517150045","article-title":"Biological activities and synthetic approaches of dihydropyrimidinones and thiones - an updated review","volume":"12","author":"Naikoo","year":"2016","journal-title":"Curr. Bioact. Compd."},{"key":"10.1016\/j.ejmech.2025.117526_bib158","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1021\/ol035649y","article-title":"Switchable catalysis: modular synthesis of functionalized Pyrimidinones via selective sulfide and halide cross-coupling chemistry","volume":"5","author":"Kusturin","year":"2003","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib159","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1021\/jo1003482","article-title":"Desulfitative cross-coupling of protecting group-free 2-thiouracil derivatives with organostannanes","volume":"75","author":"Sun","year":"2010","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib160","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1021\/cc0700041","article-title":"5-Aroyl-3,4-dihydropyrimidin-2-one library generation via automated sequential and parallel microwave-assisted synthesis techniques","volume":"9","author":"Pisani","year":"2007","journal-title":"J. Comb. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib161","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-2006-958443","article-title":"Synthesis of 5-aroyldihydropyrimidinones via liebeskind-srogl thiol ester-boronic acid cross-couplings","volume":"2007","author":"Prokopcov\u00e1 Leonardo","year":"2007","journal-title":"Synlett"},{"key":"10.1016\/j.ejmech.2025.117526_bib162","doi-asserted-by":"crossref","first-page":"20784","DOI":"10.1039\/D0RA03763J","article-title":"Recent advances in the synthesis of biologically and pharmaceutically active quinoline and its analogues: a review","volume":"10","author":"Weyesa","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117526_bib163","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.1074331","article-title":"Recent advances in functionalized quinoline scaffolds and hybrids\u2014exceptional pharmacophore in therapeutic medicine","volume":"10","author":"Elebiju","year":"2023","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib164","doi-asserted-by":"crossref","first-page":"18594","DOI":"10.1039\/D2RA02896D","article-title":"Recent advances in chemistry and therapeutic potential of functionalized quinoline motifs \u2013 a review","volume":"12","author":"Ajani","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117526_bib165","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1055\/s-0039-1690765","article-title":"Palladium-catalyzed\/copper-mediated desulfurization and aryl--ation of quinoline-2-(1H)-thione for rapid access to quinoline derivatives","volume":"52","author":"Lu Fu-Hu","year":"2020","journal-title":"Synthesis (Stuttg)."},{"key":"10.1016\/j.ejmech.2025.117526_bib166","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1039\/C7CC07633A","article-title":"Base-catalyzed thio-lactamization of 2-(1-arylvinyl)anilines with CS2 for the synthesis of quinoline-2-thiones","volume":"54","author":"Wang","year":"2018","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2025.117526_bib167","unstructured":"S. Khadem, R.J. Marles, Biological activity of natural 2-quinolinones, Nat. Prod. Res. (n.d.) 1\u201315."},{"key":"10.1016\/j.ejmech.2025.117526_bib168","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ejmech.2014.12.004","article-title":"The chemistry and biological activity of heterocycle-fused quinolinone derivatives: a review","volume":"97","author":"Shiro","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib169","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s11094-023-02794-4","article-title":"Anticancer activity\u2013structure relationship of quinolinone-core compounds: an overall review","volume":"56","author":"Beker","year":"2023","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejmech.2025.117526_bib170","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27020412","article-title":"Synthesis and biological activity of 3-(heteroaryl)quinolin-2(1H)-ones bis-heterocycles as potential inhibitors of the protein folding machinery Hsp90","volume":"27","author":"Larghi","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117526_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106126","article-title":"Natural isoquinoline alkaloids: pharmacological features and multi-target potential for complex diseases","volume":"177","author":"Plazas","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.117526_bib172","doi-asserted-by":"crossref","first-page":"10174","DOI":"10.1021\/ja036558z","article-title":"Development of a versatile stepwise, three-component reaction for diversity-oriented synthesis","volume":"125","author":"Chen","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117526_bib173","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1021\/jacs.7b00363","article-title":"Enantioselective alkyne conjugate addition enabled by readily tuned atropisomeric P,N-ligands","volume":"139","author":"Mishra","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117526_bib174","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1143\/JJAP.45.568","article-title":"Synthesis and photophysical studies of iridium complexes having different ligands","volume":"45","author":"Rho","year":"2006","journal-title":"Jpn. J. Appl. Phys."},{"key":"10.1016\/j.ejmech.2025.117526_bib175","doi-asserted-by":"crossref","first-page":"12971","DOI":"10.1021\/ja034732d","article-title":"Homoleptic cyclometalated iridium complexes with highly efficient red phosphorescence and application to organic light-emitting diode","volume":"125","author":"Tsuboyama","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117526_bib176","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/med.21703","article-title":"Biologically active isoquinoline alkaloids covering 2014\u20132018","volume":"40","author":"Shang","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.117526_bib177","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1021\/jm0210008","article-title":"Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist","volume":"46","author":"Gitto","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib178","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1177\/0091270004267592","article-title":"Pharmacokinetics and safety of solifenacin succinate in healthy young men","volume":"44","author":"Smulders","year":"2004","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117526_bib179","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1016\/j.bmcl.2009.02.098","article-title":"1-Aryl-3,4-dihydroisoquinoline inhibitors of JNK3","volume":"19","author":"Christopher","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib180","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ejmech.2006.03.005","article-title":"Affinity of 1-aryl-1,2,3,4-tetrahydroisoquinoline derivatives to the ion channel binding site of the NMDA receptor complex","volume":"41","author":"Ludwig","year":"2006","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib181","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12640-013-9402-7","article-title":"1-Methyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine with unexpected mechanism of action: new vistas of therapeutic application","volume":"25","author":"Antkiewicz-Michaluk","year":"2014","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejmech.2025.117526_bib182","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1055\/s-0034-1379109","article-title":"New synthetic approach for the preparation of 1-Aryl-3,4-dihydro-isoquinolines by liebeskind\u2013srogl reaction","volume":"25","author":"\u00c1br\u00e1nyi-Balogh P\u00e9ter","year":"2014","journal-title":"Synlett"},{"key":"10.1016\/j.ejmech.2025.117526_bib183","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1007\/s00706-015-1564-y","article-title":"Total synthesis of racemic 1-aryl-tetrahydroisoquinoline alkaloids","volume":"146","author":"\u00c1br\u00e1nyi-Balogh","year":"2015","journal-title":"Monatshefte F\u00fcr Chemie - Chem. Mon."},{"key":"10.1016\/j.ejmech.2025.117526_bib184","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2174\/1389557521666210927123831","article-title":"Quinoxaline: a chemical moiety with spectrum of interesting biological activities","volume":"22","author":"Sharma","year":"2022","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib185","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ejmech.2017.11.064","article-title":"Quinoxaline: an insight into the recent pharmacological advances","volume":"143","author":"Tariq","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib186","series-title":"Mechanism of Action of Antieukaryotic and Antiviral Compounds,","first-page":"173","article-title":"Echinomycin, triostin, and related antibiotics BT","author":"Waring","year":"1979"},{"key":"10.1016\/j.ejmech.2025.117526_bib187","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fphar.2016.00064","article-title":"Quinoxaline 1,4-di-N-oxides: biological activities and mechanisms of actions","volume":"7","author":"Cheng","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117526_bib188","doi-asserted-by":"crossref","DOI":"10.3390\/ph16081174","article-title":"Quinoxaline 1,4-dioxides: advances in chemistry and chemotherapeutic drug development","volume":"16","author":"Buravchenko","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.117526_bib189","series-title":"Springer Berlin Heidelberg, Berlin, Heidelberg","first-page":"29","article-title":"Beirut reaction BT - name reactions: a collection of detailed reaction mechanisms","author":"Li","year":"2003"},{"key":"10.1016\/j.ejmech.2025.117526_bib190","article-title":"New quinoxaline-1,4-dioxides derived from Beirut reaction of benzofuroxane with active methylene nitriles","volume":"3","author":"V Dotsenko","year":"2021","journal-title":"Chem. Proc."},{"key":"10.1016\/j.ejmech.2025.117526_bib191","doi-asserted-by":"crossref","first-page":"9559","DOI":"10.1016\/S0040-4020(98)00515-8","article-title":"4-(2,2-Dimethyldioxalan-4-yl)-5-(pterin-6-yl)-1,3-dithiol-2-ones proligands relating to the cofactor of the oxomolybdoenzymes","volume":"54","author":"Dinsmore","year":"1998","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2025.117526_bib192","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1039\/b209217d","article-title":"Synthesis of 1,3-dithiol-2-ones as proligands related to molybdopterin","volume":"1","author":"Bradshaw","year":"2003","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib193","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1016\/S0040-4039(99)00822-9","article-title":"Synthesis of 3-aryl and 3-heterocyclic quinoxalin-2-ylamines via Pd-catalyzed cross-coupling reactions","volume":"40","author":"Jack Li","year":"1999","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib194","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1002\/ejoc.201200433","article-title":"Near room temperature cross-coupling reactions of arene boronic acids with a quinoxaline 1,4-dioxide benzylsulfanyl derivative","volume":"2012","author":"Dahbi","year":"2012","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib195","article-title":"Chemical characteristics, synthetic methods, and biological potential of quinazoline and quinazolinone derivatives","volume":"2014","author":"Asif","year":"2014","journal-title":"Int. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib196","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/cbdd.14129","article-title":"A comprehensive review of recent advances in the biological activities of quinazolines","volume":"100","author":"Gomaa","year":"2022","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2025.117526_bib197","article-title":"Quinazolinone-based hybrids with diverse biological activities: a mini-review","volume":"27","author":"Rezaeinasab","year":"2022","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.ejmech.2025.117526_bib198","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1039\/C7MD00097A","article-title":"An insight into the therapeutic potential of quinazoline derivatives as anticancer agents","volume":"8","author":"Shagufta","year":"2017","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejmech.2025.117526_bib199","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3987\/COM-15-S(T)12","article-title":"Conversion of 2-Thioxo-2,3-dihydroquinazolin-4(1H)-ones to N(3)-unsubstituted 2-(Het)Arylquinazolin-4(3H)-ones by copper-mediated Pd-catalysed cross-coupling reactions","volume":"93","author":"Kri\u0161\u010di\u016bnien\u0117","year":"2016","journal-title":"Heterocycles"},{"key":"10.1016\/j.ejmech.2025.117526_bib200","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/syn.20205","article-title":"Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907","volume":"58","author":"Kristiansen","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.ejmech.2025.117526_bib201","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1042\/bj3570275","article-title":"Fatty acids inhibit growth-factor-induced diacylglycerol kinase alpha activation in vascular smooth-muscle cells","volume":"357","author":"Du","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2025.117526_bib202","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1038\/sj.npp.1300555","article-title":"Decreased hippocampal 5-HT(2A) receptor binding in older depressed patients using [18F]altanserin positron emission tomography","volume":"29","author":"Sheline","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejmech.2025.117526_bib203","doi-asserted-by":"crossref","first-page":"106710","DOI":"10.1039\/C5RA21108E","article-title":"Advances in 1,2,4-triazepines chemistry","volume":"5","author":"Elattar","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117526_bib204","series-title":"Pyrrolo [1,2-b] [1,2,5] Triazepines, a Process and Intermediates for Their Preparation and Their Use as Medicaments","author":"Hamer","year":"1985"},{"key":"10.1016\/j.ejmech.2025.117526_bib205","series-title":"Intermediates for Pyrrolo[1,2-B][1,2,5]triazepines","author":"Hamer","year":"1985"},{"key":"10.1016\/j.ejmech.2025.117526_bib206","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1021\/jo4001228","article-title":"Design and synthesis of pyrrolotriazepine derivatives: an experimental and computational study","volume":"78","author":"Menges","year":"2013","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib207","series-title":"Pyrido(3,4-f)pyrrolo(1,2-b)(1,2,5)triazepines","author":"Effland","year":"1988"},{"key":"10.1016\/j.ejmech.2025.117526_bib208","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1007\/s00706-016-1831-6","article-title":"Synthesis of 1, 4-diarylpyrrolotriazepine derivatives by two diverse strategies","volume":"147","author":"F\u00f6ldesi","year":"2016","journal-title":"Monatshefte F\u00fcr Chemie-Chemical Mon."},{"key":"10.1016\/j.ejmech.2025.117526_bib209","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1055\/s-0034-1380538","article-title":"Synthesis of three new tricyclic ring systems: pyrrolotriazepines condensed with an imidazole, a triazole, or a tetrazole ring","volume":"26","author":"Milen Tam\u00e1s","year":"2015","journal-title":"Synlett"},{"key":"10.1016\/j.ejmech.2025.117526_bib210","series-title":"Xanthine Derivative Pest Control Agents","author":"Nathanson","year":"1985"},{"key":"10.1016\/j.ejmech.2025.117526_bib211","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/ps.6834","article-title":"Synthesis and evaluation of novel xanthine-acrylamides and xanthine-acrylates as insecticidal agents","volume":"78","author":"Zhang","year":"2022","journal-title":"Pest Manag. Sci."},{"key":"10.1016\/j.ejmech.2025.117526_bib212","doi-asserted-by":"crossref","first-page":"12330","DOI":"10.1021\/acs.jafc.2c03876","article-title":"Synthesis, crystal structures, and biological activity evaluation of novel xanthine derivatives containing a pyrethroid moiety","volume":"70","author":"Zhang","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib213","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2018.e00829","article-title":"Xanthine scaffold: scope and potential in drug development","volume":"4","author":"Singh","year":"2018","journal-title":"Heliyon"},{"key":"10.1016\/j.ejmech.2025.117526_bib214","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11094-022-02661-8","article-title":"Recent advances in the biological significance of xanthine and its derivatives: a review","volume":"56","author":"Kapri","year":"2022","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejmech.2025.117526_bib215","series-title":"BT - Pharmacology and Therapeutics of Asthma and COPD","first-page":"63","article-title":"Xanthines and phosphodiesterase inhibitors","author":"Spina","year":"2017"},{"key":"10.1016\/j.ejmech.2025.117526_bib216","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1021\/jm051268+","article-title":"Novel 1,3-disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) xanthines: high affinity and selective A2B adenosine receptor antagonists","volume":"49","author":"V Kalla","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib217","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1021\/jm990421v","article-title":"Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A2B adenosine receptors","volume":"43","author":"Kim","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib218","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1002\/chem.201100037","article-title":"Palladium-catalyzed direct arylations of azoles with aryl silicon and tin reagents","volume":"17","author":"Han","year":"2011","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2025.117526_bib219","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1021\/ol0702324","article-title":"Palladium-catalyzed arylation of electron-rich heterocycles with aryl chlorides","volume":"9","author":"Chiong","year":"2007","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib220","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1021\/ol200065s","article-title":"Double C\u2212H activation: the palladium-catalyzed direct C-arylation of xanthines with arenes","volume":"13","author":"Malakar","year":"2011","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib221","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1021\/ol902079g","article-title":"Copper-mediated amidation of heterocyclic and aromatic C\u2212H bonds","volume":"11","author":"Wang","year":"2009","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib222","doi-asserted-by":"crossref","first-page":"11307","DOI":"10.1039\/c2cc36711d","article-title":"Transition metal-free direct C\u2013H bond thiolation of 1,3,4-oxadiazoles and related heteroarenes","volume":"48","author":"Zou","year":"2012","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2025.117526_bib223","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1016\/j.tetlet.2013.08.097","article-title":"Copper-catalyzed direct thiolation of xanthines and related heterocycles with disulfides","volume":"54","author":"He","year":"2013","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib224","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1039\/c004698c","article-title":"The biological potential of flavones","volume":"27","author":"Verma","year":"2010","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2025.117526_bib225","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s13765-017-0271-2","article-title":"Flavones with inhibitory effects on glycogen synthase kinase 3\u03b2","volume":"60","author":"Jung","year":"2017","journal-title":"Appl. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib226","doi-asserted-by":"crossref","DOI":"10.1016\/j.tetlet.2022.153882","article-title":"Synthesis of functionalized flavones from 3-halo-2-(methylthio)-4H-chromen-4-ones","volume":"100","author":"Elagamy","year":"2022","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib227","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1134\/S0026893321040105","article-title":"Antiviral and antimicrobial nucleoside derivatives: structural features and mechanisms of action","volume":"55","author":"Zenchenko","year":"2021","journal-title":"Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.117526_bib228","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/135965350100603S01","article-title":"An introduction to nucleoside and nucleotide analogues","volume":"6","author":"Squires","year":"2001","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.ejmech.2025.117526_bib229","doi-asserted-by":"crossref","first-page":"14379","DOI":"10.1021\/acs.chemrev.6b00209","article-title":"Metabolism, biochemical actions, and chemical synthesis of anticancer nucleosides, nucleotides, and base analogs","volume":"116","author":"Shelton","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.117526_bib230","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.1051525","article-title":"Nucleobase-modified nucleosides and nucleotides: applications in biochemistry, synthetic biology, and drug discovery","volume":"10","author":"Berdis","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib231","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14020260","article-title":"Oligonucleotide therapeutics: from discovery and development to patentability","volume":"14","author":"Moumn\u00e9","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2025.117526_bib232","doi-asserted-by":"crossref","DOI":"10.1002\/ejoc.202101061","article-title":"Direct access to unique C-5\u2019-Acyl modified nucleosides through liebeskind\u2013srogl cross-coupling reaction","volume":"2022","author":"Maverick","year":"2022","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib233","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1021\/acs.joc.5b02375","article-title":"Structural basis of duplex thermodynamic stability and enhanced nuclease resistance of 5\u2032-C-methyl pyrimidine-modified oligonucleotides","volume":"81","author":"V Kel\u2032in","year":"2016","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib234","doi-asserted-by":"crossref","first-page":"10101","DOI":"10.1093\/nar\/gkaa750","article-title":"Synthesis, chirality-dependent conformational and biological properties of siRNAs containing 5\u2032-(R)- and 5\u2032-(S)-C-methyl-guanosine","volume":"48","author":"Mikami","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.117526_bib235","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1093\/nar\/gkv162","article-title":"Identification of metabolically stable 5\u2032-phosphate analogs that support single-stranded siRNA activity","volume":"43","author":"Prakash","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.117526_bib236","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.tetlet.2011.11.036","article-title":"Synthesis of 6-aryl-2\u2032-deoxyuridine nucleosides via a Liebeskind cross-coupling methodology","volume":"53","author":"K\u00f6gler","year":"2012","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib237","doi-asserted-by":"crossref","first-page":"7379","DOI":"10.1016\/j.tet.2011.07.040","article-title":"The efficient synthesis of 2-arylpyrimidine acyclic nucleoside phosphonates using Liebeskind\u2013Srogl cross-coupling reaction","volume":"67","author":"B\u0159ehov\u00e1","year":"2011","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2025.117526_bib238","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.616863","article-title":"Overview of biologically active nucleoside phosphonates","volume":"8","author":"Groaz","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib239","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1016\/j.bmc.2005.12.060","article-title":"The purines: potent and versatile small molecule inhibitors and modulators of key biological targets","volume":"14","author":"Legraverend","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib240","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1039\/D2PY00545J","article-title":"Highly fluorescent purine-containing conjugated copolymers with tailored optoelectronic properties","volume":"13","author":"O'Connell","year":"2022","journal-title":"Polym. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib241","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jphotochemrev.2018.07.001","article-title":"Base-modified fluorescent purine nucleosides and nucleotides for use in oligonucleotide probes","volume":"36","author":"Saito","year":"2018","journal-title":"J. Photochem. Photobiol. C Photochem. Rev."},{"key":"10.1016\/j.ejmech.2025.117526_bib242","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1055\/s-0033-1340734","article-title":"Palladium-catalyzed cross-coupling between 8-substituted 6-thiophenyl-purines and b-oronic acids","volume":"46","author":"Vabre Julien","year":"2014","journal-title":"Synthesis (Stuttg)."},{"key":"10.1016\/j.ejmech.2025.117526_bib243","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1039\/c3ob40881g","article-title":"Direct C\u2013H sulfenylation of purines and deazapurines","volume":"11","author":"Kle\u010dka","year":"2013","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib244","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2174\/0929867013372193","article-title":"Glycosides in medicine: \u201cThe role of glycosidic residue in biological activity\u201d","volume":"8","author":"Kren","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib245","article-title":"Recent advances on natural aryl-C-glycoside scaffolds: structure, bioactivities, and synthesis\u2014a comprehensive review","volume":"27","author":"Liu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117526_bib246","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2023.108856","article-title":"Recent advances on synthesis of C-glycosides","volume":"530","author":"Parida","year":"2023","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejmech.2025.117526_bib247","doi-asserted-by":"crossref","first-page":"6294","DOI":"10.1038\/s41467-021-26585-1","article-title":"C-Glycoside metabolism in the gut and in nature: identification, characterization, structural analyses and distribution of C-C bond-cleaving enzymes","volume":"12","author":"Mori","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117526_bib248","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175354","article-title":"SGLT2 inhibitors for the composite of cardiorenal outcome in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials","volume":"936","author":"Chen","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117526_bib249","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.phytochem.2011.11.001","article-title":"Unprecedented furan-2-carbonyl C-glycosides and phenolic diglycosides from Scleropyrum pentandrum","volume":"74","author":"Disadee","year":"2012","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2025.117526_bib250","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.carres.2012.09.015","article-title":"Carbohydrate derivatives from the roots of Brassica rapa ssp. campestris and their effects on ROS production and glutamate-induced cell death in HT-22 cells","volume":"372","author":"Wu","year":"2013","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejmech.2025.117526_bib251","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2021.132255","article-title":"Synthesis of (non-classical) C-acyl-glycosides via Liebeskind\u2013Srogl coupling: scope, limitation, improved synthesis and antioxidant activity of scleropentaside A","volume":"92","author":"Zhang","year":"2021","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2025.117526_bib252","first-page":"8302","article-title":"Cyanide-free synthesis of glycosyl carboxylic acids and application for the synthesis of scleropentaside A, org","volume":"22","author":"Zou","year":"2020","journal-title":"Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib253","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2021.131955","article-title":"A general approach to C-Acyl glycosides via palladium\/copper Co-catalyzed coupling reaction of glycosyl carbothioates and arylboronic acids","volume":"82","author":"Wang","year":"2021","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2025.117526_bib254","doi-asserted-by":"crossref","DOI":"10.1002\/ajoc.202100665","article-title":"Synthesis of C4-Acyl-tetrofuranosides and C5-Acyl-pentopyranosides enabled by the liebeskind-srogl cross-coupling reaction","volume":"11","author":"Xu","year":"2022","journal-title":"Asian J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib255","doi-asserted-by":"crossref","DOI":"10.1002\/ajoc.202100665","article-title":"Synthesis of C4-Acyl-tetrofuranosides and C5-Acyl-pentopyranosides enabled by the liebeskind-srogl cross-coupling reaction","volume":"11","author":"Xu","year":"2022","journal-title":"Asian J. Org. Chem."},{"issue":"Suppl","key":"10.1016\/j.ejmech.2025.117526_bib256","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1194\/jlr.R800095-JLR200","article-title":"Update of the LIPID MAPS comprehensive classification system for lipids","volume":"50","author":"Fahy","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejmech.2025.117526_bib257","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.1021\/cr200295k","article-title":"Bioinformatics and systems biology of the lipidome","volume":"111","author":"Subramaniam","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.117526_bib258","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.3390\/ijms14024242","article-title":"Lipid nanotechnology","volume":"14","author":"Mashaghi","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117526_bib259","doi-asserted-by":"crossref","DOI":"10.3390\/cells11132058","article-title":"Sphingosine-1-Phosphate (S1P) and S1P signaling pathway modulators, from current insights to future perspectives","volume":"11","author":"Bravo","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.117526_bib260","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1016\/j.tet.2005.02.075","article-title":"Chemistry and biology of sphingolipids","volume":"61","author":"Liao","year":"2005","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2025.117526_bib261","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415510","article-title":"Sphingosine as a new antifungal agent against Candida and Aspergillus spp","volume":"23","author":"Hashemi Arani","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117526_bib262","series-title":"Synthesis of Sphingosines and Their Derivatives","author":"Liebeskind","year":"2008"},{"key":"10.1016\/j.ejmech.2025.117526_bib263","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1021\/ml2000164","article-title":"Novel synthesis and biological evaluation of enigmols as therapeutic agents for treating prostate cancer","volume":"2","author":"Garnier-Amblard","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib264","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113168","article-title":"Novel pentacyclic triterpenes exhibiting strong neuroprotective activity in SH-SY5Y cells in salsolinol- and glutamate-induced neurodegeneration models","volume":"213","author":"Gonzalez","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib265","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1016\/j.bmc.2014.04.061","article-title":"Synthesis of triterpenoid triazine derivatives from allobetulone and betulonic acid with biological activities","volume":"22","author":"Dinh Ngoc","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib266","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1021\/np5002048","article-title":"Studies toward the development of antiproliferative neoclerodanes from salvinorin A","volume":"77","author":"Vasiljevik","year":"2014","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2025.117526_bib267","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1021\/ar500203h","article-title":"The quest for a simple bioactive analog of paclitaxel as a potential anticancer agent","volume":"47","author":"Kingston","year":"2014","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.117526_bib268","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1021\/ci025640v","article-title":"A Structure\u2212Activity study of taxol, taxotere, and derivatives using the electronic indices methodology (EIM)","volume":"43","author":"Braga","year":"2003","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.ejmech.2025.117526_bib269","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25245986","article-title":"A compressive review about Taxol(\u00ae): history and future challenges","volume":"25","author":"Gallego-Jara","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117526_bib270","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1016\/j.tetlet.2011.10.148","article-title":"Synthesis of medium-sized carbocyclic ketones via the intramolecular B-alkyl Liebeskind\u2013Srogl coupling reaction","volume":"52","author":"Tsuna","year":"2011","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib271","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1239658","article-title":"Recent insights about pyrrolidine core skeletons in pharmacology","volume":"14","author":"Poyraz","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117526_bib272","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/14786410802340861","article-title":"Anti-cancer effect of two alkaloids: 2R and 2S-bgugaine on mastocytoma P815 and carcinoma Hep","volume":"23","author":"Benamar","year":"2009","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2025.117526_bib273","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1055\/s-2006-957490","article-title":"A new toxic alkylpyrrolidine alkaloid from Arisarum vulgare","volume":"64","author":"Melhaoui","year":"1998","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2025.117526_bib274","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2020.131789","article-title":"Catalytic asymmetric total syntheses of (R)-bgugaine and (R)-irnidine","volume":"78","author":"Maddocks","year":"2021","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2025.117526_bib275","doi-asserted-by":"crossref","first-page":"7948","DOI":"10.1002\/anie.201203935","article-title":"Enantioselective total synthesis of amphidinolide F","volume":"51","author":"Mahapatra","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.117526_bib276","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1021\/ol015741z","article-title":"Absolute stereochemistry of amphidinolide C","volume":"3","author":"Kubota","year":"2001","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib277","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1021\/ja00210a029","article-title":"The first twenty-five membered macrocyclic lactone with potent antineoplastic activity from the cultured dinoflagellate Amphidinium sp","volume":"110","author":"Kobayashi","year":"1988","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117526_bib278","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.7164\/antibiotics.44.1259","article-title":"Amphidinolide F, a new cytotoxic macrolide from the marine dinoflagellate Amphidinium sp","volume":"44","author":"Kobayashi","year":"1991","journal-title":"J. Antibiot. (Tokyo)."},{"key":"10.1016\/j.ejmech.2025.117526_bib279","doi-asserted-by":"crossref","first-page":"9534","DOI":"10.1002\/anie.201301700","article-title":"Total synthesis of amphidinolide F","volume":"52","author":"Valot","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.117526_bib280","doi-asserted-by":"crossref","first-page":"10792","DOI":"10.1021\/ja404796n","article-title":"Exploiting hidden symmetry in natural products: total syntheses of amphidinolides C and F","volume":"135","author":"Mahapatra","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117526_bib281","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1002\/chem.201405790","article-title":"Concise total syntheses of amphidinolides C and F","volume":"21","author":"Valot","year":"2015","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2025.117526_bib282","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1021\/acs.orglett.8b01020","article-title":"Total synthesis of the marine macrolide amphidinolide F","volume":"20","author":"Ferri\u00e9","year":"2018","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib283","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1016\/j.tetlet.2015.04.035","article-title":"Liebeskind\u2013Srogl cross-coupling on \u03b3-carboxyl-\u03b3-butyrolactone derivatives: application to the side chain of amphidinolides C and F","volume":"56","author":"Fenneteau","year":"2015","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib284","doi-asserted-by":"crossref","DOI":"10.1002\/ajoc.202400564","article-title":"Coumestans: synthesis, isolation, and bioactivity","author":"Naik","year":"2025","journal-title":"Asian J. Org. Chem. n\/a"},{"key":"10.1016\/j.ejmech.2025.117526_bib285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11094-013-0886-5","article-title":"Synthesis and biological activity of coumestan derivatives (Review)","volume":"47","author":"Tuskaev","year":"2013","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejmech.2025.117526_bib286","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1021\/jo400984h","article-title":"Pd-catalyzed C-S activation for [3 + 3] annulation of 2-(methylthio)benzofuran-3-carboxylates and 2-hydroxyphenylboronic acids: synthesis of coumestan derivatives","volume":"78","author":"Liu","year":"2013","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib287","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0040-4039(01)98960-9","article-title":"Studies on orchidaceae alkaloids. IX","volume":"11","author":"Leander","year":"1968","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib288","doi-asserted-by":"crossref","first-page":"12254","DOI":"10.1039\/D1RA01480C","article-title":"Medicinal chemistry perspectives of 1,2,3,4-tetrahydroisoquinoline analogs \u2013 biological activities and SAR studies","volume":"11","author":"Faheem","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117526_bib289","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1007\/s00706-015-1564-y","article-title":"Total synthesis of racemic 1-aryl-tetrahydroisoquinoline alkaloids","volume":"146","author":"\u00c1br\u00e1nyi\u2010Balogh","year":"2015","journal-title":"Monatshefte F\u00fcr Chemie - Chem. Mon."},{"key":"10.1016\/j.ejmech.2025.117526_bib290","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1021\/acs.orglett.8b03432","article-title":"Flueggeacosines A\u2013C, dimeric securinine-type alkaloid analogues with neuronal differentiation activity from Flueggea suffruticosa","volume":"20","author":"Wu","year":"2018","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib291","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1021\/jacs.2c03861","article-title":"Synthesis of dimeric securinega alkaloid flueggeacosine B: from Pd-catalyzed cross-coupling to Cu-catalyzed cross-dehydrogenative coupling","volume":"144","author":"Kang","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117526_bib292","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0040-4039(00)86674-5","article-title":"Goniodomin a, a novel polyether macrolide from the dinoflagellate goniodoma pseudogoniaulax","volume":"29","author":"Murakami","year":"1988","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib293","doi-asserted-by":"crossref","first-page":"26026","DOI":"10.1016\/S0021-9258(19)74488-3","article-title":"Goniodomin A induces modulation of actomyosin ATPase activity mediated through conformational change of actin","volume":"268","author":"Furukawa","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib294","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0014-2999(98)00164-2","article-title":"Modulation of actomyosin ATPase by goniodomin A differs in types of cardiac myosin","volume":"346","author":"Yasuda","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117526_bib295","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.2042-7158.1998.tb06899.x","article-title":"An antifungal polyether macrolide, increases the filamentous actin content of 1321N1 human astrocytoma cells","volume":"50","author":"Mizuno","year":"1998","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117526_bib296","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1021\/ol902217q","article-title":"Toward the total synthesis of goniodomin A, an actin-targeting marine polyether macrolide: convergent synthesis of the C15\u2212C36 segment","volume":"11","author":"Saito","year":"2009","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib297","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0040-4020(02)01491-6","article-title":"Natural anti-HIV agents. Part 3: litseaverticillols A\u2013H, novel sesquiterpenes from Litsea verticillata","volume":"59","author":"Zhang","year":"2003","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2025.117526_bib298","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0031-9422(01)00454-X","article-title":"Natural anti-HIV agents\u2014part I: (+)-demethoxyepiexcelsin and verticillatol from Litsea verticillata","volume":"59","author":"Hoang","year":"2002","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2025.117526_bib299","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1271\/bbb.60253","article-title":"Enantioselective synthesis of the (1S,5R)-Enantiomer of litseaverticillols A and B","volume":"70","author":"Morita","year":"2006","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.ejmech.2025.117526_bib300","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1021\/ol053122a","article-title":"Enantioselective total synthesis of litseaverticillols A and B","volume":"8","author":"Morita","year":"2006","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib301","series-title":"Structural Requirements for Cannabinoid Receptor Probes BT - Cannabinoids","first-page":"209","author":"Thakur","year":"2005"},{"key":"10.1016\/j.ejmech.2025.117526_bib302","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1021\/jm501165d","article-title":"Probing the carboxyester side chain in controlled deactivation (\u2212)-\u03948-Tetrahydrocannabinols","volume":"58","author":"Nikas","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib303","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1124\/jpet.106.104109","article-title":"Pharmacological characterization of novel water-soluble cannabinoids","volume":"318","author":"Martin","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2025.117526_bib304","doi-asserted-by":"crossref","first-page":"7839","DOI":"10.1021\/acs.joc.7b00988","article-title":"C1\u2032-Azacycloalkyl hexahydrocannabinols","volume":"82","author":"Ho","year":"2017","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib305","first-page":"63","article-title":"Sarpagine and related alkaloids., alkaloids","volume":"76","author":"Namjoshi","year":"2016","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117526_bib306","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1021\/ja0296024","article-title":"Biomimetic entry to the sarpagan family of indole alkaloids: total synthesis of +-geissoschizine and +-N-methylvellosimine","volume":"125","author":"Deiters","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117526_bib307","doi-asserted-by":"crossref","first-page":"11762","DOI":"10.1002\/anie.201206015","article-title":"Nature-inspired stereospecific total synthesis of P-(+)-Dispegatrine and four other monomeric sarpagine indole alkaloids","volume":"51","author":"Edwankar","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.117526_bib308","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1021\/jo000126e","article-title":"Enantiospecific total synthesis of the sarpagine related indole alkaloids talpinine and talcarpine as well as the improved total synthesis of alstonerine and anhydromacrosalhine-methine via the asymmetric Pictet\u2212Spengler reaction","volume":"65","author":"Yu","year":"2000","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib309","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1002\/chem.202000415","article-title":"Towards the sarpagine-ajmaline-macroline family of indole alkaloids: enantioselective synthesis of an N-demethyl alstolactone diastereomer","volume":"26","author":"Dagoneau","year":"2020","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2025.117526_bib310","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1021\/ol501856v","article-title":"Peganumine A, a \u03b2-carboline dimer with a new octacyclic scaffold from peganum harmala","volume":"16","author":"Wang","year":"2014","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib311","doi-asserted-by":"crossref","first-page":"11148","DOI":"10.1021\/jacs.6b07846","article-title":"Enantioselective synthesis of (+)-Peganumine A","volume":"138","author":"Piemontesi","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117526_bib312","doi-asserted-by":"crossref","first-page":"8805","DOI":"10.1021\/jacs.3c02317","article-title":"Total syntheses of scabrolide A and yonarolide","volume":"145","author":"Serrano","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117526_bib313","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1021\/jacs.1c12401","article-title":"Total syntheses of scabrolide A and nominal scabrolide B","volume":"144","author":"Meng","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117526_bib314","doi-asserted-by":"crossref","first-page":"8585","DOI":"10.1021\/jacs.0c02513","article-title":"The total synthesis of (\u2212)-Scabrolide A","volume":"142","author":"Hafeman","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117526_bib315","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1021\/jo00376a047","article-title":"Scytophycins, cytotoxic and antimycotic agents from the cyanophyte Scytonema pseudohofmanni","volume":"51","author":"Ishibashi","year":"1986","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib316","doi-asserted-by":"crossref","DOI":"10.1016\/j.tetlet.2022.154250","article-title":"Toward the total synthesis of scytophycins: synthesis of the C7\u2013C21 fragments of scytophycins A, B, and C","volume":"114","author":"Ohyoshi","year":"2023","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib317","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1021\/ol0352299","article-title":"Total synthesis of scytophycin C. 2. Coupling reaction of the C(1)\u2212C(18) segment and the C(19)\u2212C(31) segment, a key macrolactonization, and the crucial terminal amidation reaction","volume":"5","author":"Nakamura","year":"2003","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib318","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1021\/ol035227o","article-title":"Total synthesis of scytophycin C. 1. Stereoselective syntheses of the C(1)\u2212C(18) segment and the C(19)\u2212C(31) segment","volume":"5","author":"Nakamura","year":"2003","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib319","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1021\/jo962189w","article-title":"Total synthesis of scytophycin C","volume":"62","author":"Paterson","year":"1997","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib320","doi-asserted-by":"crossref","first-page":"11935","DOI":"10.1016\/S0040-4020(98)00702-9","article-title":"The total synthesis of scytophycin C. Part 1: stereocontrolled synthesis of the C1\u2013C32 protected seco acid","volume":"54","author":"Paterson","year":"1998","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2025.117526_bib321","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1021\/np000602w","article-title":"Verbenachalcone, a novel dimeric dihydrochalcone with potentiating activity on nerve growth factor-action from Verbena littoralis","volume":"64","author":"Li","year":"2001","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2025.117526_bib322","doi-asserted-by":"crossref","first-page":"7903","DOI":"10.1016\/S0040-4020(02)00915-8","article-title":"Utilization of a copper-catalyzed diaryl ether synthesis for the preparation of verbenachalcone","volume":"58","author":"Xing","year":"2002","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2025.117526_bib323","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1016\/j.tetlet.2004.02.154","article-title":"A total synthesis of verbenachalcone, a bioactive diaryl ether from Verbena littoralis","volume":"45","author":"Tanabe","year":"2004","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib324","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1016\/j.tetlet.2010.08.073","article-title":"Liebeskind\u2013Srogl cross coupling mediated synthesis of verbenachalcone","volume":"51","author":"Dandepally","year":"2010","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib325","doi-asserted-by":"crossref","first-page":"8220","DOI":"10.1039\/c3cs60153f","article-title":"Be squared: expanding the horizon of squaric acid-mediated conjugations","volume":"42","author":"Wurm","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2025.117526_bib326","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112872","article-title":"Squaric acid analogues in medicinal chemistry","volume":"209","author":"Chas\u00e1k","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib327","doi-asserted-by":"crossref","first-page":"8539","DOI":"10.1021\/jo701331m","article-title":"Pd-catalyzed, Cu(I)-Mediated cross-couplings of bisarylthiocyclobutenediones with boronic acids and organostannanes","volume":"72","author":"Aguilar-Aguilar","year":"2007","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib328","doi-asserted-by":"crossref","first-page":"40863","DOI":"10.1039\/C9RA08275A","article-title":"Synthesis and characterization of cyclobutenedione-bithiophene \u03c0-conjugated polymers: acetal-protecting strategy for Kumada-Tamao-Corriu coupling polymerization between aryl bromide and Grignard reagents","volume":"9","author":"Ohishi","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117526_bib329","doi-asserted-by":"crossref","first-page":"76","DOI":"10.24820\/ark.5550190.p011.459","article-title":"Synthesis bis-thienyl-substituted cyclobutenedione via the Liebeskind-Srogl and Stille cross-coupling reactions","volume":"2021","author":"V Kokate","year":"2021","journal-title":"ARKIVOC (Gainesville, FL, U. S.)"},{"key":"10.1016\/j.ejmech.2025.117526_bib330","doi-asserted-by":"crossref","DOI":"10.3998\/ark.5550190.0005.115","article-title":"Synthesis of squaric acid ester-containing ferrocene derivatives","volume":"2004","author":"Aguilar-Aguilar","year":"2004","journal-title":"ARKIVOC (Gainesville, FL, U. S.)"},{"key":"10.1016\/j.ejmech.2025.117526_bib331","doi-asserted-by":"crossref","first-page":"34808","DOI":"10.1021\/acsomega.4c04314","article-title":"The liebeskind\u2013srogl cross-coupling reaction as a crucial step in the synthesis of new squaramide-based antituberculosis agents","volume":"9","author":"Chas\u00e1k","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2025.117526_bib332","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1021\/ol701628z","article-title":"Selective cross-couplings. Sequential Stille\u2212Liebeskind\/srogl reactions of 3-Chloro-4-arylthiocyclobutene-1,2-dione","volume":"9","author":"Aguilar-Aguilar","year":"2007","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib333","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2174\/138955712803832735","article-title":"A short overview on the medicinal chemistry of (\u2014)-shikimic acid","volume":"12","author":"Estevez","year":"2012","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib334","doi-asserted-by":"crossref","first-page":"20599","DOI":"10.1039\/c3ra43755h","article-title":"Design, synthesis, and preliminary biological evaluation of novel ketone derivatives of shikimic acid","volume":"3","author":"Jiang","year":"2013","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117526_bib335","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000368800","article-title":"Phosphodiesterase inhibitors for the treatment of asthma and chronic obstructive pulmonary disease","volume":"165","author":"Page","year":"2014","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.ejmech.2025.117526_bib336","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF02737831","article-title":"CDP840: a novel inhibitor of PDE-4","volume":"29","author":"Perry","year":"1998","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2025.117526_bib337","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1183\/09031936.97.10051008","article-title":"The effect of a novel orally active selective PDE4 isoenzyme inhibitor (CDP840) on allergen-induced responses in asthmatic subjects","volume":"10","author":"Harbinson","year":"1997","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejmech.2025.117526_bib338","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0960-894X(02)00202-0","article-title":"CDP840. A prototype of a novel class of orally active anti-Inflammatory phosphodiesterase 4 inhibitors","volume":"12","author":"Alexander","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib339","doi-asserted-by":"crossref","first-page":"8082","DOI":"10.1039\/c3ob41646a","article-title":"Synthesis of PDE IV inhibitors. First asymmetric synthesis of two of GlaxoSmithKline's highly potent Rolipram analogues","volume":"11","author":"Zhmurov","year":"2013","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib340","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1016\/j.bmcl.2005.08.036","article-title":"Discovery of a substituted 8-arylquinoline series of PDE4 inhibitors: structure\u2013activity relationship, optimization, and identification of a highly potent, well tolerated, PDE4 inhibitor","volume":"15","author":"Macdonald","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib341","doi-asserted-by":"crossref","first-page":"6933","DOI":"10.1021\/jo0510437","article-title":"Rapid synthesis of CDP840 with 2-pyrimidyl vinyl sulfide as a platform","volume":"70","author":"Muraoka","year":"2005","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib342","doi-asserted-by":"crossref","first-page":"8421","DOI":"10.1021\/jm101288t","article-title":"Synthesis and Structure\u2212Activity relationships of aza- and diazabiphenyl analogues of the antitubercular drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)","volume":"53","author":"Kmentova","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib343","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2022.100128","article-title":"Pretomanid for tuberculosis treatment: an update for clinical purposes","volume":"3","author":"Occhineri","year":"2022","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117526_bib344","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25184137","article-title":"Recent progress in the discovery and development of 2-nitroimidazooxazines and 6-nitroimidazooxazoles to treat tuberculosis and neglected tropical diseases","volume":"25","author":"Showalter","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117526_bib345","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.bmcl.2015.12.002","article-title":"Synthesis and evaluation of pretomanid (PA-824) oxazolidinone hybrids","volume":"26","author":"Rakesh","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117526_bib346","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112849","article-title":"Re-evaluating pretomanid analogues for Chagas disease: hit-to-lead studies reveal both in vitro and in vivo trypanocidal efficacy","volume":"207","author":"Thompson","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117526_bib347","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40265-014-0331-4","article-title":"Delamanid: a review of its use in patients with multidrug-resistant tuberculosis","volume":"75","author":"Blair","year":"2015","journal-title":"Drugs"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425002910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425002910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:24:18Z","timestamp":1745454258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425002910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":347,"alternative-id":["S0223523425002910"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117526","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Liebeskind\u2013Srogl cross-coupling reaction towards the synthesis of biologically active compounds","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117526","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117526"}}